CytoMed Therapeutics • GDTC
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
$25.4M
Market Cap • 25/04/20242018
(há 6 anos)
2023
(1 year ago)
NASDAQ
Listagem
Singapore
27
N° de Empregados • 2023Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
GDTCSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.